Although misleading health information is not a new phenomenon, no standards exist to
assess consumers’ ability to detect and subsequently reject misinformation. Part of this deficit …

Limited data exist about US travelers’ knowledge, risk perceptions, and behaviors related to
the Zika virus (ZIKV). Using an internet research panel, in March 2017, we surveyed 1,202 …

Background Consumers and primary care physicians (PCPs) sometimes encounter deceptive
promotional claims about prescription drugs. Whether consumers and PCPs can detect …

Introduction: Little is known about how repeated exposure to direct-to-consumer prescription
drug promotion can impact consumers’ retention and perceptions of drug information. The …

Purpose Understanding patient perceptions of prescription drug risks and benefits is an
important component of determining risk-benefit tradeoffs and helping patients make informed …

Objective Images demonstrating a prescription drug’s efficacy are often included in direct-to-consumer
television advertisements. The current research assessed whether exaggerated …

… Kelly, and Mihaela Johnson fielded the survey and analyzed the responses. Leila C.
Kahwati … Kelly, Mihaela Johnson, Meera Viswanathan read and approved the final submitted …

Background The Prescribing Information (PI) is the US Food and Drug Administration (FDA)'s
primary tool for communicating a summary of the essential scientific information needed for …

Introduction An estimated 116 million American adults (47.3%) have hypertension. Most
adults with hypertension do not have it controlled—3 in 4 (92.1 million) US adults with …

Advertisers sometimes include price‐comparison information in direct‐to‐consumer (DTC)
prescription drug ads because consumers may value such savings when considering drug …